These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30975451)

  • 21. Alternative prostate cancer screening strategies--in response.
    Gulati R; Etzioni R
    Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
    [No Abstract]   [Full Text] [Related]  

  • 22. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
    Borkowetz A
    Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
    [No Abstract]   [Full Text] [Related]  

  • 23. Insights from the PLCO trial about prostate cancer screening.
    Gulati R; Albertsen PC
    Cancer; 2017 Feb; 123(4):546-548. PubMed ID: 27906455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General practitioner (GP)'s view on screening for prostate cancer in the Netherlands: the impact of a randomized trial.
    Schröder FH
    BJU Int; 2013 Jul; 112(1):4-5. PubMed ID: 23759003
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer screening.
    Eastham J
    Investig Clin Urol; 2017 Jul; 58(4):217-219. PubMed ID: 28681029
    [No Abstract]   [Full Text] [Related]  

  • 26. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
    Klotz L
    Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening.
    Loeb S
    J Clin Oncol; 2016 Aug; 34(23):2684-6. PubMed ID: 27325846
    [No Abstract]   [Full Text] [Related]  

  • 28. [STHLM3 test could help improve prostate cancer screening].
    Heß J
    Urologe A; 2016 May; 55(5):660. PubMed ID: 26943662
    [No Abstract]   [Full Text] [Related]  

  • 29. Interpreting the Statistics on Potential Benefits of Prostate Cancer Screening.
    Jones K
    Am Fam Physician; 2017 Apr; 95(7):412-413. PubMed ID: 28409604
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate cancer screening: Do guidelines matter?
    Kearns JT; Gore JL
    Cancer; 2016 Dec; 122(24):3760-3761. PubMed ID: 27656862
    [No Abstract]   [Full Text] [Related]  

  • 31. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostate cancer screening.
    Faigen M
    Med J Aust; 2013 Nov; 199(9):585. PubMed ID: 24182219
    [No Abstract]   [Full Text] [Related]  

  • 33. When to Discuss Prostate Cancer Screening with Your Patients.
    Ledford CJW; Seehusen DA
    Am Fam Physician; 2019 Jul; 100(2):69-70. PubMed ID: 31305050
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.
    Carter HB
    JAMA; 2018 May; 319(18):1866-1868. PubMed ID: 29800999
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostate cancer: Screening and treatment: where do we go from here?
    Saad F
    Nat Rev Clin Oncol; 2017 Jan; 14(1):7-8. PubMed ID: 27874064
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostate cancer screening: what we know, don't know, and believe.
    Brawley OW
    Ann Intern Med; 2012 Jul; 157(2):135-6. PubMed ID: 22801675
    [No Abstract]   [Full Text] [Related]  

  • 37. The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer.
    Godtman RA; Carlsson S; Holmberg E; Stranne J; Hugosson J
    J Urol; 2016 May; 195(5):1390-1396. PubMed ID: 26678954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms.
    Vickers AJ
    Ann Intern Med; 2017 Oct; 167(7):509-510. PubMed ID: 28869975
    [No Abstract]   [Full Text] [Related]  

  • 39. [PSA-based prostate cancer screening, a slippery slope].
    Legoupil C; Hill C
    Rev Prat; 2018 Oct; 68(8):832-838. PubMed ID: 30869445
    [No Abstract]   [Full Text] [Related]  

  • 40. Discuss prostate cancer screening with your doctor.
    The Lancet
    Lancet; 2017 Apr; 389(10079):1582. PubMed ID: 28443541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.